GUMDROP : JHMI J4805 A Randomized Phase II study to determine the effect of 2 different doses of AVE0005 in patients with metastatic RCC

Description:This randomized phase II trial is studying two different doses of VEGF Trap to see compare well they work in treating patients with metastatic or unresectable kidney cancer. VEGF Trap may stop the growth of kidney cancer by blocking blood flow to the tumor
Link:http://clinicaltrials.gov/ct2/show/NCT00357760
Site:Johns Hopkins University
Principal Investigator:Michael A. Carducci, MD